+499.5%
MRNA vs NVMI
+53.9%
+445.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVMI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +5.5% | -7.7% | -3.2% |
| 7D | +5.5% | +6.6% | -1.1% | +4.1% |
| 30D | +158.7% | -7.5% | +166.3% | +162.7% |
| 3M | +182.1% | -28.5% | +210.6% | +196.7% |
| 6M | +151.8% | -15.7% | +167.6% | +145.4% |
| YTD | +393.6% | +13.3% | +380.2% | +334.0% |
| 1Y | +499.5% | +48.3% | +451.2% | +364.1% |
| All | +499.5% | +53.9% | +445.6% | +364.1% |
Cumulative growth
Daily Returns
Daily percentage return beside NVMI.
Daily Out/Under-Performance
Portfolio return minus NVMI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVMI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVMI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling